Warsaw Stock Exchange: Ryvu Therapeutics 1Q23 in line with expectations (NEUTRAL)STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: RELPOL ANALYTICAL REPORT – SUMMARYSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Rainbow Tours released 1Q23 preliminary figuresSTOCKSGPW’s Analytical Coverage Support Programme 3.0
SFD - 1Q23 results review - WSE - GPW’s Analytical Coverage Support Programme 3.0STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Analyst Comment – Forever Entertainment Q1’23 ResultsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: MCI Capital - Results for 1Q23 - a quiet start to the yearSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Votum - Key indicators for the banking segment in April and MaySTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: CreativeForge Games - ANALYST COMMENT – CFG Q1’23 RESULTSSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: DataWalk - 1Q23 preliminary results revealed – drop of revenues by 23% yoySTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: LSI Software - Preliminary revenues at PLN 12.9 million in 1Q23STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: ELEKTROTIM ANALYTICAL REPORT - SUMMARYSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Unimot - Preliminary consolidated 1Q23 results revealedSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Analyst comment – SIMFABRIC Q4’22 RESULTSSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - Action - Event: Sales and gross profit margin for April revealed.STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: SELENA FM - ANALYTICAL REPORT – SUMMARYSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: MLP Group - Growth story to continue (SUMMARY)STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Pekabex (PBX) - So far so good (SUMMARY)STOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Vivid Games SA - Analytical report - New CEO, new strategy – new Vivid Games?STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Ferro - 1Q23 financial results previewSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Bioton – (Last valuation: 5.34 PLN/share as of 20.04.2023)STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange – Enter Air – analyst comment - Q4’22 ResultsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Mirbud – Valuation, relative valuation, ESG section, risk to fair valueSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Mirbud - Economic slowdown means stabilizing costsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Sygnity: Key risks, Valuation and DCF valuation – Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Sygnity: sell (reiterated). Workable Strategy and Expensive MultiplesSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Action - Event: 4Q22 financial results released – close to our forecasts.STOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Unimot - Event: Management outlook, following the publication of 4Q22 resultsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Unimot - Event: 4Q22 results revealed; Adjusted EBITDA close to the preliminary figures published earlierFOREXGPW’s Analytical Coverage Support Programme 3.0
WSE: Unimot - PLN 13.69 per share dividend proposed from FY22 profitsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: MCI Capital - the worst is already priced in?STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: DataWalk - 4Q22 final results released – close to preliminary figuresSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Ryvu Therapeutics – ValuationSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Ryvu Therapeutics: Termination of partnering deal with Galapagos, Valuation summary and moreSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Ryvu Therapeutics: Milestones payments from Exelixis, Share issue and 4Q22 results & Conference highlightsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Ryvu Therapeutics - One more partnering deal in 2023e?STOCKSGPW’s Analytical Coverage Support Programme 3.0
DataWalk - 4Q22 final results released – close to preliminary figures – Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Unimot: Event: Conference concerning acquired assets from Lotos and PKN OrlenSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: CREATIVEFORGE GAMES - analytical report - summarySTOCKSGPW’s Analytical Coverage Support Programme 3.0
ZEW Kogeneracja - Financial forecasts & Macro assumptions - Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: ZEW Kogeneracja - Valuation, Risk factors and peers valuationSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: ZEW Kogeneracja - Price cap and price cap calculation for power plantsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: ZEW Kogeneracja - Price caps reduce profits on electricity generationSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Unimot - Ultimate purchase of Lotos Terminale - Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Unimot - Initial agreement to purchase 80% shares of P2TSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: LSI Software - New contract signed (net PLN 16.9 million)STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Agora - summary of report - A new openingSTOCKSGPW’s Analytical Coverage Support Programme 3.0
HFM Market Analyst: Polish interest rates could be cut in 2024 rather than the end of 2023 like the NBP statedECONOMYAndria Pichidi
Ferro - 4Q22 financial results summary – Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: VIGO Photonics: Breakthrough contracts for now out of sightSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - Voxel: 4Q22 financial results summarySTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: LSI Software - 4Q22 results previewSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Action (WSE:ACT): EGM to vote on share buyback increaseSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Voxel: 4Q22 financial results preview - Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: Unimot - Event: Finalization of purchase of 90% of Olavion sharesSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - Grodno: 3Q22/23 financial results review and 4Q22/23 financial results previewSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - SFD: Growth in sales to be maintainedSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Ailleron: 4Q22 results: Record quarter, continued high y/y earnings growthSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Unimot - Event: Purchase of additional railway cisterns – Warsaw Stock ExchangeSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Votum - Event: Key indicators for the banking segment in January and FebruarySTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - Sygnity: Final Results for Q1 2022/23STOCKSGPW’s Analytical Coverage Support Programme 3.0
Lockheed Is Facing Performance Issues Concerning Some Of Its Products, Which May Hurt Its ResultsECONOMYConotoxia Comments
Warsaw Stock Exchange: Action - Event: 4Q22 results’ forecastsSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange - IMC | 4Q22 sales volumes beat Pekao estimates by 12%, though the risk of another Russian offensive is looming large on UkraineSTOCKSGPW’s Analytical Coverage Support Programme 3.0
WSE: BioMaxima - PLN 1.8 million subsidy to buy the production lineSTOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchange: Votum - Key indicators for the banking segment in December 2022 and January 2023STOCKSGPW’s Analytical Coverage Support Programme 3.0
Warsaw Stock Exchgange: Action - December sales and gross profit marginSTOCKSGPW’s Analytical Coverage Support Programme 3.0